How pediatric innovation is currently funded? It’s enough?
Join this event to get a roundup from philanthropic efforts to emerging venture capital firms focused in pediatric-first companies.
AGENDA
- 16h30-17h00 · Welcome
- 17h00-18h00 · Annual i4KIDS Assembly (language: catalan. Open to the whole ecosystem)
- 18h15-19h00 · Impact Investment in Pediatric Innovation · Marc Ramis, Venture Partner at Ship2B Ventures. (language: english) · How pediatric innovation is currently funded? It’s enough? Marc Ramis will provide us with a roundup of philanthropic efforts and emerging venture capital firms focused on pediatric-first companies.
- 19h00-20h00 · Cocktail Networking
About Marc Ramis · Venture Partner at Ship2B Ventures
Marc is passionate about launching ventures in the field of Children’s Health. Also, he brings more than 15 years of experience creating novel biomedical ventures. Recently, Marc was a co-founder & CEO at Rejuveron Senescence Therapeutics AG (Zürich), Ninevah Therapeutics Ltd (London) and Senolytic Therapeutics Inc (Boston). He is a Venture Partner at Ship2B Ventures. Marc also is a Board Member of multiple early-stage biotech companies such as Oniria Therapeutics SL, Gate2Brain SL or Nanobots Therapeutics SL. Marc gained a DPhil in Biochemistry from the University of Oxford in 2006, and a Harvard Business School PLD Program in 2011.
The event is going to be held at Tech Barcelona Pier07 · Via Laietana 26, Barcelona.
The event has the participation of Ship2B Ventures, and the collaboration of Sant Joan de Déu, Generalitat de Catalunya (Dept. Recerca i Universitats, Secretaria General), and Tech Barcelona.
